Welcome to our new website
As well as being able to load content faster than ever before, you'll now find it's much easier to find all the content you need about the Asian business world.
Health Technology
Peptidream Inc.
- 5,440.00 JPY
- +30.00
- +0.55%
Japan
Mar 19, 2019Ticker
TKS(4587)Prev. close
5,410Market cap (JPY)
668,191.25MMarket cap (USD)
6,004.86MShares
123.51M
In the news
- Japan's university startups top 2,000 for first time Mar 9, 2018
- Out of the lab, into the market Feb 5, 2018
- Drugmakers are drawn to Japan's laboratory in space Jan 29, 2018
- Japanese bioventures receiving healthy dose of investor funds Jan 24, 2018
- Univ. of Tokyo startups are targets of new $220m tech fund Jan 24, 2018 See more articles on Peptidream Inc.
Business Summary
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.
Financial Highlights
| Jun 2018 | JPY | USD |
| Revenue | 6,426.89M | 58.24M |
| Gross Profit | 4,580.75M | 41.51M |
| Operating income | 2,910.98M | 26.38M |
| Income before tax | 3,151.73M | 28.56M |
| Net income | 2,335.21M | 21.16M |
| EBITDA | 3,424.32M | 31.03M |
| Diluted EPS | 17.79 | 0.16 |
| Dividends Per Share | 0 | 0 |
| Total Assets | 16,502.26M | 148.98M |
| Total liabilities | 1,793.54M | 16.19M |
| Total equity | 14,708.71M | 132.79M |
| Operating cash flow | 1,022.71M | 9.26M |
| Currency in JPY | Currency in USD |
Historical Data
| Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | |
| Revenue | 818.90M | 2,474.49M | 4,327.87M | 4,895.74M | 6,426.89M |
| Gross Profit | 503.67M | 1,752.47M | 3,241.08M | 3,530.02M | 4,580.75M |
| Operating income | 201.36M | 1,391.12M | 2,548.08M | 2,490.41M | 2,910.98M |
| Income before tax | 221.99M | 1,493.37M | 2,365.81M | 2,624.15M | 3,151.73M |
| Net income | 148.51M | 1,004.16M | 1,581.28M | 1,890.75M | 2,335.21M |
| EBITDA | 275.10M | 1,494.19M | 2,691.08M | 2,685.28M | 3,424.32M |
| Diluted EPS | 1.36 | 7.83 | 12.26 | 14.56 | 17.79 |
| Dividends Per Share | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 5,999.27M | 7,738.44M | 11,956.40M | 13,628.45M | 16,502.26M |
| Total liabilities | 136.06M | 826.01M | 1,713.64M | 1,447.65M | 1,793.54M |
| Total equity | 5,863.20M | 6,912.43M | 10,242.75M | 12,180.80M | 14,708.71M |
| Operating cash flow | 72.17M | 1,386.14M | 1,533.05M | 1,530.77M | 1,022.71M |
| Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | |
| Revenue | 8.10M | 21.58M | 37.08M | 44.87M | 58.24M |
| Gross Profit | 4.98M | 15.28M | 27.77M | 32.35M | 41.51M |
| Operating income | 1.99M | 12.13M | 21.83M | 22.82M | 26.38M |
| Income before tax | 2.19M | 13.02M | 20.27M | 24.05M | 28.56M |
| Net income | 1.47M | 8.76M | 13.54M | 17.33M | 21.16M |
| EBITDA | 2.72M | 13.03M | 23.05M | 24.61M | 31.03M |
| Diluted EPS | 0.01 | 0.06 | 0.10 | 0.13 | 0.16 |
| Dividends Per Share | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 59.21M | 63.24M | 116.54M | 121.29M | 148.98M |
| Total liabilities | 1.34M | 6.75M | 16.70M | 12.88M | 16.19M |
| Total equity | 57.87M | 56.49M | 99.84M | 108.40M | 132.79M |
| Operating cash flow | 0.71M | 12.09M | 13.13M | 14.03M | 9.26M |
Valuation Measures
| Jun 2018 | |
| PER | 238.24 |
| ROA | 15.50% |
| ROE | 17.36% |
| Operating margin | 45.29% |
| Profit margin | 36.33% |
Key executives
- President & Representative Director: Patrick Crawford Reid
- Director, Manager-Research & Development: Keiichi Masuya
- Manager-Public & Investor Relations: Toshiyuki Iwata
Shareholders
- KUBOTA KIICHI (11.5%)
- SUGA HIROAKI (8.8%)
- J.O. Hambro Capital Management Ltd. (6.6%)
- JPMorgan Asset Management (Japan) Ltd. (4.8%)
- Asset Management One Co., Ltd. (3.9%)
- REID PATRICK C (3.4%)
- OppenheimerFunds, Inc. (2.4%)
- Nomura Asset Management Co., Ltd. (2.0%)
- Baillie Gifford & Co. (1.9%)
- MURAKAMI HIROSHI /PEPTIDREAM INC/ (1.7%)
Contact Details
- Website:http://peptidream.com
- Address: 3-25-23 Tonomachi, Kawasaki-Ku, Kawasaki, 210-0821, Japan
- Phone: +81.44.270.1300
Related Companies
- Peptidream Board Incentive Plan
- Peptidream Employee Incentive Plan
- PharmaDesign, Inc. (Japan) /Pharma Research Bus/
- PharmaDesign, Inc. (Japan)
Competitors
Copyright © 2019 FactSet Research Systems Inc. All rights reserved.
Last Updated on 19 Mar, 2019